Clinical trial
Clinical Study on Positron Emission Tomography (PET) Imaging, Distribution and Pharmacokinetics of 89 Zirconium (Zr)-CD147 in Patients With Solid Tumors
NCT04841421 is registered in ClinicalTrials.gov with Sinotau Pharmaceutical Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study on Positron Emission Tomography (PET) Imaging, Distribution and Pharmacokinetics of 89 Zirconium (Zr)-CD147 in Patients With Solid Tumors
- Lead sponsor
- Sinotau Pharmaceutical Group
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- May 1, 2021
- Completion date
- March 1, 2024
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumor